| 05/14/2026 4:12 PM | First Tracks Biotherapeutics (2091349) Filer | Form 424B3 | |
| 05/14/2026 3:32 PM | First Tracks Biotherapeutics (2091349) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/14/2026 3:05 PM | First Tracks Biotherapeutics (2091349) Issuer Lizzul Paul F. (1711462) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 3:05 PM | First Tracks Biotherapeutics (2091349) Issuer Tamboli Ajim (1855684) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 3:05 PM | Faga Daniel (1673528) Reporting First Tracks Biotherapeutics (2091349) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 3:05 PM | First Tracks Biotherapeutics (2091349) Issuer STONE BENJAMIN (2128786) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 3:05 PM | FENTON DENNIS M (1184627) Reporting First Tracks Biotherapeutics (2091349) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 3:05 PM | First Tracks Biotherapeutics (2091349) Issuer Orwin John A (1477384) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 3:05 PM | First Tracks Biotherapeutics (2091349) Issuer Jain Rita (1707797) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 3:05 PM | First Tracks Biotherapeutics (2091349) Issuer Schmid John P. (1478916) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 3:05 PM | First Tracks Biotherapeutics (2091349) Issuer Marquet Magda (1631486) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TRAX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for First Tracks Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/14/2026 3:05 PM | First Tracks Biotherapeutics (2091349) Issuer Ware J. Anthony (1715429) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/12/2026 11:15 PM | First Tracks Biotherapeutics (2091349) Filer | Form EFFECT | |
| 04/23/2026 5:08 PM | First Tracks Biotherapeutics (2091349) Issuer Tamboli Ajim (1855684) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/23/2026 5:08 PM | First Tracks Biotherapeutics (2091349) Issuer Tamboli Ajim (1855684) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 4:07 PM | EcoR1 Capital, LLC (1587114) Reporting First Tracks Biotherapeutics (2091349) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 4:09 PM | EcoR1 Capital, LLC (1587114) Filed by First Tracks Biotherapeutics (2091349) Subject | Form SCHEDULE 13G | |
| 04/22/2026 4:07 PM | EcoR1 Capital, LLC (1587114) Reporting First Tracks Biotherapeutics (2091349) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/22/2026 3:19 PM | First Tracks Biotherapeutics (2091349) Issuer STONE BENJAMIN (2128786) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/22/2026 3:05 PM | First Tracks Biotherapeutics (2091349) Issuer Marquet Magda (1631486) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:05 PM | Faga Daniel (1673528) Reporting First Tracks Biotherapeutics (2091349) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:05 PM | ANAPTYSBIO, INC (1370053) Reporting First Tracks Biotherapeutics (2091349) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:05 PM | First Tracks Biotherapeutics (2091349) Issuer Jain Rita (1707797) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:05 PM | FENTON DENNIS M (1184627) Reporting First Tracks Biotherapeutics (2091349) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:05 PM | First Tracks Biotherapeutics (2091349) Issuer Orwin John A (1477384) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:05 PM | First Tracks Biotherapeutics (2091349) Issuer Schmid John P. (1478916) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:05 PM | First Tracks Biotherapeutics (2091349) Issuer Ware J. Anthony (1715429) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:05 PM | First Tracks Biotherapeutics (2091349) Issuer Lizzul Paul F. (1711462) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/20/2026 4:23 PM | First Tracks Biotherapeutics (2091349) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/17/2026 4:02 PM | First Tracks Biotherapeutics (2091349) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 04/01/2026 3:38 PM | First Tracks Biotherapeutics (2091349) Issuer Jain Rita (1707797) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/01/2026 3:38 PM | First Tracks Biotherapeutics (2091349) Issuer Ware J. Anthony (1715429) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/01/2026 3:31 PM | ANAPTYSBIO, INC (1370053) Reporting First Tracks Biotherapeutics (2091349) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/01/2026 3:33 PM | Faga Daniel (1673528) Reporting First Tracks Biotherapeutics (2091349) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/01/2026 3:34 PM | First Tracks Biotherapeutics (2091349) Issuer Lizzul Paul F. (1711462) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/01/2026 3:34 PM | First Tracks Biotherapeutics (2091349) Issuer Orwin John A (1477384) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/01/2026 3:35 PM | First Tracks Biotherapeutics (2091349) Issuer Marquet Magda (1631486) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/01/2026 3:36 PM | FENTON DENNIS M (1184627) Reporting First Tracks Biotherapeutics (2091349) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/01/2026 3:37 PM | First Tracks Biotherapeutics (2091349) Issuer Schmid John P. (1478916) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/01/2026 2:36 PM | First Tracks Biotherapeutics (2091349) Filer | Form CERT | |
| 03/27/2026 3:31 PM | First Tracks Biotherapeutics (2091349) Filer | Form 10-12B/A | |
SpaceX is offering you shares. Don't take them. (Ad) SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. But at a $1.75 trillion valuation and 266 times earnings, early institutional holders may be looking for someone to sell to.
Dylan Jovine has identified a small company in Musk's supply chain that builds the power infrastructure behind Colossus - still trading at a fraction of its potential value. No IPO allocation required. Get the backdoor ticker free before the SpaceX IPO launches |